Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Abroad (travel likely)RecruitingPHASE2

Conditions

High-risk HPV (Any Strain) · LSIL, Low Grade Squamous Intraepithelial Lesion · ASC-US · HPV Infection · Cervical Abnormalities · Uterine Cervical Dysplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Prince of Wales Hospital, Shatin, New Territories, Hong Kong

    Contact: Study coordinator (Bell (Hei Yi) Yung) · p2trialhk@amplexd.com · +852 5165 6846
    Contact: Principal Investigator (Kar Kei Yung, MBBS (HK), MRCOG, FHKCOG, FHKA)
Study leads
  • Kar Kei Yung, MBBS (HK), MRCOG, FHKCOG, FHKA

    Principal Investigator

    Prince of Wales Hospital, Chinese University of Hong Kong